Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Comprehensive Loss

v3.23.2
Condensed Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Condensed Statements of Comprehensive Loss [Abstract]        
License and collaborations revenue $ 3,674 $ 0 $ 5,423 $ 0
Operating expenses:        
General and administrative 4,340 1,776 6,625 3,512
Research and development 4,723 3,162 10,318 7,934
Total operating expenses 9,063 4,938 16,943 11,446
Loss from operations (5,389) (4,938) (11,520) (11,446)
Interest expense 0 (4) 0 (9)
Other income (expense), net 428 15 768 (67)
Loss before income taxes (4,961) (4,927) (10,752) (11,522)
Benefit (provision) for income taxes 0 0 0 0
Net loss (4,961) (4,927) (10,752) (11,522)
Other comprehensive loss, net of tax 0 0 0 0
Comprehensive loss $ (4,961) $ (4,927) $ (10,752) $ (11,522)
Net loss per share:        
Basic (Note 10) (in dollars per share) $ (0.24) $ (0.25) $ (0.51) $ (0.6)
Diluted (Note 10) (in dollars per share) $ (0.24) $ (0.25) $ (0.51) $ (0.6)
Number of shares used in per share calculations:        
Basic (in shares) 20,959,807 19,502,563 20,949,763 19,197,213
Diluted (in shares) 20,959,807 19,502,563 20,949,763 19,197,213